Managing adverse events after endoscopic ultrasound‐guided drainage of the biliary tract and pancreatic fluid collections : Narrative review (with video)
Endoscopic ultrasound (EUS)‐guided therapeutic procedures have become increasingly common in clinical practice. The development of EUS‐guided fine needle aspiration cytology led to the concept of interventional EUS. However, it carries a considerable risk of adverse events (AEs), which occur in approximately 23% of the procedures performed for the drainage of pancreatic fluid collections and 2.5–37.0% of those performed for drainage of the biliary tract. Although the vast majority of AEs occurring after EUS‐guided drainage are mild, a deep understanding of such events is necessary for their appropriate management. Because EUS‐guided drainage is a novel procedure, there have been few studies of the topic. To our knowledge, this is the first narrative review that focuses on the management and resolution of AEs occurring after EUS‐guided drainage of pancreatic fluid collections or the biliary tract. We also include an explanatory video..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Digestive Endoscopy - 34(2022), 2, Seite 359-366 |
| Beteiligte Personen: |
Funari, Mateus Pereira [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
Digestie Endoscopy © 2022 Japan Gastroenterological Endoscopy Society |
|---|
| Umfang: |
8 |
|---|
| doi: |
10.1111/den.14080 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY00454868X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY00454868X | ||
| 003 | DE-627 | ||
| 005 | 20230307140044.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230214s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/den.14080 |2 doi | |
| 028 | 5 | 2 | |a DEN_DEN14080.xml |
| 035 | |a (DE-627)WLY00454868X | ||
| 035 | |a (WILEY)DEN14080 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.87 |2 bkl | ||
| 100 | 1 | |a Funari, Mateus Pereira |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Managing adverse events after endoscopic ultrasound‐guided drainage of the biliary tract and pancreatic fluid collections |b Narrative review (with video) |
| 264 | 1 | |c 2022 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Digestie Endoscopy © 2022 Japan Gastroenterological Endoscopy Society | ||
| 520 | |a Endoscopic ultrasound (EUS)‐guided therapeutic procedures have become increasingly common in clinical practice. The development of EUS‐guided fine needle aspiration cytology led to the concept of interventional EUS. However, it carries a considerable risk of adverse events (AEs), which occur in approximately 23% of the procedures performed for the drainage of pancreatic fluid collections and 2.5–37.0% of those performed for drainage of the biliary tract. Although the vast majority of AEs occurring after EUS‐guided drainage are mild, a deep understanding of such events is necessary for their appropriate management. Because EUS‐guided drainage is a novel procedure, there have been few studies of the topic. To our knowledge, this is the first narrative review that focuses on the management and resolution of AEs occurring after EUS‐guided drainage of pancreatic fluid collections or the biliary tract. We also include an explanatory video. | ||
| 700 | 1 | |a Ribeiro, Igor Braga |4 aut | |
| 700 | 1 | |a Lera dos Santos, Marcos Eduardo |4 aut | |
| 700 | 1 | |a Matuguma, Sergio Eiji |4 aut | |
| 700 | 1 | |a de Moura, Eduardo Guimarães Hourneaux |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Digestive Endoscopy |g 34(2022), 2, Seite 359-366 |w (DE-627)WLY00453526X |x 14431661 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2022 |g number:2 |g pages:359-366 |g extent:8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.87 |q ASE |
| 951 | |a AR | ||
| 952 | |d 34 |j 2022 |e 2 |h 359-366 |g 8 | ||